Biolinq的动态

The medical device and medtech industry is undergoing significant changes, which is evident in the rising value of the global medical devices market from approximately $542.2 billion in 2024 to $886 billion by 2032. Read more to learn about the top 10 trends for the medical device and medtech industry in 2024: https://buff.ly/4cduhEE #MedicalDevice #MedTech #AI #MachineLearning #WearableDevice #WearableTechnology #WearableDevices #HealthWearables #RemotePatientMonitoring

Cutting-edge sterile drug delivery solutions could revolutionize how we approach patient treatment. ?? Technologies like pre-filled syringes (PFS), wearable injectors, and implantable devices enhance user convenience, foster better adherence to medication regimes, and result in improved health outcomes for patients. Yet, the development of these innovative devices demands specialized knowledge. Is your CDMO ally equipped with the necessary expertise and resources to advance your project? We are prepared and eager to assist you in introducing your PFS into the marketplace. In our most recent blog post, we delve into why choosing the right CDMO partner is crucial for successfully launching your novel sterile delivery technologies. Discover more ?? https://gag.gl/ez7GnN

2024 Medical Device Trends at a Glance: 1. Continued rise in digital therapeutics and at-home diagnostics 2. Growing use of biometric devices and wearable technology 3. The potential impact of weight loss drugs 4. Marketplace challenges within the European Union 5. Increased speed to market for medical devices 6. Greater emphasis on inclusivity and access 7. Greater focus on sustainability and environmental, social, and governance (ESG) 8. Generative AI opportunities in manufacturing and distribution

Is our medical software a SaMD (Software-as-a-Medical Device), a SiMD (Software-in-a-Medical Device), or an accessory? It's more than a technical distinction; it's the guiding force behind our design, development, and commercialization journey. Drawing inspiration from?Xenophon Papademetris, we view medical software development as an act of regulated design - undeniably creative! Curious to know more? Let's chat! Our team has a mix of hands-on expertise and regulatory strategy experience with electro-mechanical, health data systems and SaMD?? Visit us at?www.eliomedica.com?and drop us a message. ??????#SaMD?#MedicalDevice?#RegulatoryAffairs?#Eliomedica?#RegulatoryStrategy?#MedTech?#ArtificialIntelligence?#AI

Cutting-edge sterile drug delivery technologies are poised to revolutionize the way we approach patient care. ?? Innovations like pre-filled syringes (PFS), wearable injectors, and implantable devices enhance user convenience, foster adherence to treatment regimens, and result in superior health outcomes for patients. Yet, the development of these sophisticated devices demands specialized knowledge. Is your CDMO ally equipped with the necessary skills and resources to advance your project? We are eager and prepared to assist in introducing your PFS into the marketplace. In our most recent blog post, we delve into how choosing the right CDMO partner could be crucial in successfully launching your novel sterile delivery options. Discover more ?? https://gag.gl/ez7GnN

#Home_Blood_Pressure_Monitoring_Devices Market In-depth Analysis Report by Size, Share, Regional Analysis and Global Forecast to 2032. >> https://lnkd.in/g8T3EW6W Home #blood pressure monitoring devices are #electronic instruments that allow individuals to #measure and track their blood #pressure levels at home. These #devices, including digital blood pressure #monitors and smart wearable #technologies, provide a #convenient and accessible means for individuals to monitor their #cardiovascular health and share #data with healthcare #professionals for better management of #hypertension. OMRON Healthcare EMEA A&D Medical SUNTECH MEDICAL LIMITED American Diagnostics Inc. Withings Briggs Healthcare GE HealthCare Microlife AG Rossmax Graham-Field (GF Health Products, Inc) Spacelabs Healthcare Philips #medicaldevices #bloodpressure #monitoringdevices #cardiovascular #healthcareindustry #pharmaceuticalindustry #regulatory #laboratory #healthcareresearch

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #HealthcareWearableRobots #MedicalDevices #Rehabilitation #Innovation #GlobalMarket #Technology #PatientCare #Exoskeletons #Recovery #HealthcareSolutions

Let’s connect via: skin / adhesives / devices / development ?? Lohmann value chain ?? Skin as a substrate ?? Stick to skin solutions ?? Critical factors for the design of wearables Join Michael Stapleton, Lohmann GmbH & Co. KG and the industry leaders in exploring the forefront of industry trends, connecting with professionals, and gaining insights that drive progress, sign up for the upcoming #VLDDCP ??6th Drug-Device Combination Products?? ??October 15-16, 2024 ?? Berlin, Germany ??Register ?? https://buff.ly/3WjjFx0 The summit is proudly supported by ?Lohmann GmbH & Co. KG ? As a leading manufacturer and converter of pressure-sensitive adhesives and component parts for wearable, ostomy, diagnostic, and other medical applications, Lohmann delivers comprehensive solutions and provides a complete value chain, minimizing risk and accelerating your medical device innovations to market.?Find more at https://lnkd.in/dzPaeFfc The conference & expo aims to address the critical importance of ensuring harmony between drug products and their delivery mechanisms towards the successful advancement of sustainable and connected combined drug-device products #combinationproducts #design #engineering #drugdelivery #future #digital #connecteddevices #medicaldevices #compatibility #suspensions #sustainability #digitalhealth #autoinjector #injectors #medtech #wearables #drugdevelopment #DDSs #innovation #conference #summit #ssr #hfe #pharmaceuticalmanufacturing #regulatory #externalinnovation #formulation #injectabledrugs #injectables #injectiondevices #digital #materialscience #drugdevicecombination #humanfactor #humanfactorengineering

?Wearable sensors could provide a non-invasive technique for recording activity (actigraphy) in heart failure clinical trials. This easy-to-implement innovation could overcome current limitations and add a new dimension to the multimodal assessment of a patient’s functional status. ?? Watch the video below to find out more about how AstraZeneca and our partner from the University of Glasgow are collaborating in this space. #WhatScienceCanDo #HeartFailure #HealthTech

?Wearable sensors could provide a non-invasive technique for recording activity (actigraphy) in heart failure clinical trials. This easy-to-implement innovation could overcome current limitations and add a new dimension to the multimodal assessment of a patient’s functional status. ?? Watch the video below to find out more about how AstraZeneca and our partner from the University of Glasgow are collaborating in this space. #WhatScienceCanDo #HeartFailure #HealthTech